Released Oct 27, 2026, after the close
10-Q filed Oct 28, 2026, 28 days after period end · 0001425450-26-000094
On October 27, 2026, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended September 30, 2026 and making other disclosures.
The release| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $72.66M | $61.25M | $54.57M | $39.97M |
| Net Income | -$5.93M | -$11.77M | -$7.92M |
Orthopediatrics Corp · CIK 1425450 · Engraved from SEC EDGAR
| -$4.59M |
| EPS Diluted | -$0.25 | -$0.50 | -$0.34 | -$0.20 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
OrthoPediatrics reported total revenue of $72.7 million for the third quarter of 2026, up 19% from $61.2 million in the third quarter of 2025.¶2¶3
Net loss for the third quarter of 2026 was $5.9 million, or $0.25 per basic and diluted share, compared to $11.8 million, or $0.50 per share, a year earlier.¶4
Adjusted EBITDA for the third quarter of 2026 was $6.9 million, compared to $6.2 million, and free cash flow was $1.6 million compared to $3.4 million used in the prior year period.¶5¶6
The company increased its full year 2026 revenue guidance to $270.0 million to $273.0 million from its prior range of $265.0 million to $269.0 million.¶7